| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.014 | 0.8 |